However, the evidence in dMMR/MSI-H CRC is more ambiguous: even though resistance to ICIs has been linked to β2M alterations in some cases [49], β2M mutations or the absent expression of β2M do not necessarily preclude a response to ICIs [50]. Here, B2M is linked to colorectal carcinoma.